A new way to make powerful changes at will to the DNA of humans, other animals and plants, much like how a writer changes words in a story, could usher in a transformation in genetic medicine.
Scientists are not just excited about this recently discovered technique because it can snip and edit DNA with precision. It can also do the job more easily and cheaply than other gene-editing methods, making possible research that has historically been difficult, experts say.
Now some of the biologists who unlocked this tool, derived from the immune system of bacteria, are forming companies around it. Although this molecular system, known as Crispr, is not fully understood, researchers believe it can be harnessed to create therapies for intractable genetic diseases.
“In principle, this is a technology that could enable correction of genetic mutations that would otherwise lead to disease,” said Doudna, a professor of chemistry and biochemistry and molecular biology, in a telephone interview. She was among several experts who spoke at a UC Berkeley conference on the subject last month.
Ethical concerns
But because the method is in its infancy and has little precedent with the agencies that regulate medicines, it will almost certainly be a long time before a Crispr-based therapy makes it to market.
Its potential risks also concern some bioethicists.
The Latest on: Editing DNA
[google_news title=”” keyword=”Editing DNA” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Editing DNA
- Korro Announces $70 Million Private Placementon April 18, 2024 at 7:30 am
Financing led by Deep Track Capital with participation from other leading healthcare investorsPro-forma cash and cash equivalents of ...
- Colossal Announces $7.5M in New Investments in Ancient DNA Academic Researchon April 17, 2024 at 3:14 pm
Dr. Beth Shapiro, Colossal Biosciences’ chief science office, will lead the de-extinction company's ancient DNA research and oversee the distribution of funding and development of new partnerships and ...
- NC company helps bring CRISPR to high schoolson April 17, 2024 at 9:21 am
High school students across the country can now easily and affordably perform cutting-edge gene editing thanks to the new CRISPR in a Box educational kit. Burlington-based Carolina Biological Supply ...
- Lilly's Prevail walks away from gene editing collab with Precisionon April 17, 2024 at 5:48 am
Nine months after Eli Lilly’s Prevail Therapeutics reduced the biobucks value of a gene editing deal with Precision Biosciences, the Big Pharma subsidiary has ...
- We Need to be Ready for Biotech’s ChatGPT Momenton April 16, 2024 at 1:20 pm
Like the digital revolution, the biotech revolution stands to transform America’s economy as we know it, writes Eric Schmidt.
- Extinct animals could be resurrected from DNA, researchers believeon April 13, 2024 at 9:00 am
Extinct animals which are currently unknown to science could be brought back to life through ancient DNA, researchers believe. At Colossal Biosciences in Texas, scientists are already well on their ...
- Biologists reveal how gyrase resolves DNA entanglementson April 10, 2024 at 5:00 pm
The coiled telephone cord and the DNA double helix that stores the genetic material in every cell in the body have one thing in common; they both supercoil, or coil about themselves, and tangle in ...
- CRISPR Concerns Won’t Spoil Its Promise—If We Use the Right Toolson April 9, 2024 at 5:45 pm
Now is the time for anyone involved in this field to embrace the best tools available for determining that a CRISPR edit will not harm the patients we are trying to help.
- Stanford doctors help develop first FDA-approved gene-editing treatmenton April 9, 2024 at 12:28 am
The FDA recently approved Casgevy, a gene-editing medical treatment which uses CRISPR/Cas9 technology to treat sickle cell disease. Casgevy, which two Stanford faculty members contributed to via drug ...
- Cloaking Device: Liu, Joung Launch $100M Nvelop Therapeutics to Advance Delivery of Genetic Cargoon April 8, 2024 at 5:00 pm
“They’re both prolific in the field of gene editing independently ... centers on engineered DNA-free virus-like particles (eVLPs)—assemblies of viral proteins that can infect cells but ...
via Bing News